Antipsychotics are the best defense against relapse in schizophrenia, even though that protection often comes at the expense of cognitive function. Which drugs offer the greatest […]

Methadone has been shown to be highly effective for opioid use disorder (OUD). So why is it still so difficult to prescribe in the United States […]

An expert workgroup has developed the first appropriate use recommendations (AURs) for real-world use of the antiamyloid donanemab (Kisunla). “The role of appropriate use recommendations are […]

Last year, the US Centers for Disease Control and Prevention (CDC) reported a 3% decline in the number of drug overdose deaths, the largest decrease in […]

With tens of millions of euros in the offing, researchers across the European Union have eagerly taken up the gauntlet to find novel interventions for difficult-to-treat […]

A novel digital treatment designed to reduce the frequency of auditory hallucinations and associated distress in patients with psychosis has been shown to be safe and […]

The US Food and Drug Administration (FDA) has announced a voluntary manufacturer-initiated recall of more than 7000 bottles of duloxetine delayed-release capsules due to unacceptable levels […]